Biotron Limited Stock Today

BITRF Stock  USD 0.06  0.01  19.88%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 42

 
100  
 
Zero
Below Average
Biotron is trading at 0.0585 as of the 28th of March 2024. This is a 19.88 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0585. Biotron has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Biotron Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 901.94 M outstanding shares. More on Biotron Limited

Moving against Biotron Pink Sheet

  0.79NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.78NONOF Novo Nordisk ASPairCorr
  0.76BRK-A Berkshire HathawayPairCorr
  0.68REGN Regeneron Pharmaceuticals Financial Report 2nd of May 2024 PairCorr
  0.51MCHB Mechanics BankPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Biotron Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotron's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotron or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOMichelle Miller
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Biotron Limited [BITRF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotron's market, we take the total number of its shares issued and multiply it by Biotron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotron Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 901.94 M outstanding shares. Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations.
Check Biotron Probability Of Bankruptcy
Ownership Allocation
Biotron Limited retains a total of 901.94 Million outstanding shares. Biotron Limited shows 14.13 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Biotron Ownership Details

Biotron Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of Biotron jumping above the current price in 90 days from now is about 48.31%. The Biotron Limited probability density function shows the probability of Biotron pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Biotron Limited has a beta of -0.6391 suggesting as returns on benchmark increase, returns on holding Biotron are expected to decrease at a much lower rate. During the bear market, however, Biotron Limited is likely to outperform the market. Additionally, biotron Limited has an alpha of 0.1055, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.0585HorizonTargetOdds Above 0.0585
51.56%90 days
 0.06 
48.31%
Based on a normal probability distribution, the odds of Biotron to move above the current price in 90 days from now is about 48.31 (This Biotron Limited probability density function shows the probability of Biotron Pink Sheet to fall within a particular range of prices over 90 days) .

Biotron Limited Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biotron market risk premium is the additional return an investor will receive from holding Biotron long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotron. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biotron's alpha and beta are two of the key measurements used to evaluate Biotron's performance over the market, the standard measures of volatility play an important role as well.

Biotron Stock Against Markets

Picking the right benchmark for Biotron pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biotron pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biotron is critical whether you are bullish or bearish towards Biotron Limited at a given time. Please also check how Biotron's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biotron without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Biotron Corporate Directors

Biotron corporate directors refer to members of a Biotron board of directors. The board of directors generally takes responsibility for the Biotron's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biotron's board members must vote for the resolution. The Biotron board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Robert ThomasIndependent Non-Executive DirectorProfile
Stephen LocarniniDirectorProfile
Denis WadeIndependent Non-Executive DirectorProfile
Susan PondIndependent Non-Executive DirectorProfile

How to buy Biotron Pink Sheet?

Before investing in Biotron, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biotron. To buy Biotron stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biotron. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Biotron stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Biotron Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Biotron Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biotron Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Biotron Limited?

The danger of trading Biotron Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biotron is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biotron. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biotron Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotron Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Biotron Pink Sheet analysis

When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Please note, there is a significant difference between Biotron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.